Copyright: ©Author(s) 2026.
World J Psychiatry. Apr 19, 2026; 16(4): 115490
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.115490
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.115490
Table 2 Comparison of Depressive Symptom Assessment Scale total scores, mean ± SD
| Scale | Total (n = 202) | Non-depression group (n = 89) | Depression group (n = 113) | Z/t value | P value |
| PHQ-9 total score [M (Q1, Q3)] | 7.0 (3.0, 12.0) | 2.0 (1.0, 4.0) | 11.0 (8.0, 15.0) | -12.84 | < 0.001 |
| PSQI total score [M (Q1, Q3)] | 8.5 (5.0, 12.0) | 6.0 (4.0, 8.0) | 11.0 (8.0, 14.0) | -8.67 | < 0.001 |
| FSS total score | 4.2 ± 1.8 | 3.1 ± 1.4 | 5.1 ± 1.6 | -9.15 | < 0.001 |
| PSS-10 total score | 18.6 ± 7.3 | 14.2 ± 5.8 | 22.1 ± 6.9 | -8.42 | < 0.001 |
- Citation: Dong S, Mou HL, Zhang H, Ye T. Correlation analysis of depressive symptoms and immune function indicators in patients with malignant melanoma. World J Psychiatry 2026; 16(4): 115490
- URL: https://www.wjgnet.com/2220-3206/full/v16/i4/115490.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i4.115490